Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
ML

Michael Lainchbury — 16 Patents

Genentech: 10 patents #288 of 2,392Top 15%
CLCancer Research Technology Limited: 6 patents #58 of 493Top 15%
Harlow, GB: #27 of 388 inventorsTop 7%
Overall (All Time): #284,196 of 4,157,543Top 7%
16 Patents All Time
Michael Lainchbury has been granted 16 US patents while listed as an inventor at Genentech. The first was granted in 2015 and the most recent in August 2025. Michael Lainchbury ranks #284,196 of 4,157,543 US inventors in our database (top 6.8%). Patent records list Michael Lainchbury in Harlow, GB.

Issued Patents All Time

Showing 1–16 of 16 patents

Patent #TitleCo-InventorsDate
12378249 Isoquinoline compounds and uses thereof Jun Liang, Sushant Malhotra, Rohan Mendonca, Naomi Rajapaksa, Michael Siu +16 more 2025-08-05
12297210 Naphthyridine compounds and uses thereof Terry Kellar, Jun Liang, Sushant Malhotra, Rohan Mendonca, Michael Siu +15 more 2025-05-13
12208088 Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof Sushant Malhotra, Craig Stivala, BinQing Wei, Bryan Chan, Timothy Heffron +8 more 2025-01-28
11944606 Azaindoles as inhibitors of HPK1 Timothy Heffron, Sushant Malhotra, BinQing Wei, Bryan Chan, Lewis Gazzard +4 more 2024-04-02
11787792 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-carbonitrile and therapeutic uses thereof Ian Collins, Thomas Peter Matthews, Tatiana Faria Da Fonseca Mchardy, James Daniel OSBORNE, Michael Ian Walton +1 more 2023-10-17
11566003 Isoquinolines as inhibitors of HPK1 Bryan Chan, Joy Drobnick, Lewis Gazzard, Timothy Heffron, Jun Liang +16 more 2023-01-31
11034692 Naphthyridines as inhibitors of HPK1 Bryan Chan, Blake Daniels, Joy Drobnick, Lewis Gazzard, Timothy Heffron +22 more 2021-06-15
10952995 Azaindoles as inhibitors of HPK1 Timothy Heffron, Sushant Malhotra, BinQing Wei, Bryan Chan, Lewis Gazzard +4 more 2021-03-23
10407424 Naphthyridines as inhibitors of HPK1 Bryan Chan, Naomi Rajapaksa, Michael Siu, Craig Stivala, John Tellis +22 more 2019-09-10
10259806 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof Ian Collins, Thomas Peter Matthews, Tatiana Faria Da Fonseca Mchardy, James Daniel OSBORNE, Michael Ian Walton +1 more 2019-04-16
9951064 Azaindazole compounds as inhibitors of T790M containing EGFR mutants Marian C. Bryan, Bryan Chan, Francois Diederich, Jennafer Dotson, Emily Hanan +3 more 2018-04-24
9890152 Aminopyrimidine compounds as inhibitors of T790M containing EGFR mutants Marian C. Bryan, Bryan Chan, Emily Hanan, Timothy Heffron, Hans Purkey +4 more 2018-02-13
9765059 5-(Pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use Ian Collins, Thomas Peter Matthews, John Charles Reader 2017-09-19
9663503 5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof Ian Collins, Thomas Peter Matthews, Tatiana Faria Da Fonseca Mchardy, James Daniel OSBORNE, Michael Ian Walton +1 more 2017-05-30
9403797 5-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use Ian Collins, Thomas Peter Matthews, John Charles Reader 2016-08-02
9040540 5-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use Ian Collins, Thomas Peter Matthews, John Charles Reader 2015-05-26